Company Filing History:
Years Active: 2010-2014
Title: The Innovative Contributions of Xing-Xian Yu
Introduction
Xing-Xian Yu is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. With a total of 10 patents, he has made remarkable advancements in the modulation of gene expression, particularly in relation to fibroblast growth factor receptor 4 and diacylglycerol acyltransferase 2.
Latest Patents
One of his latest patents focuses on the "Antisense modulation of fibroblast growth factor receptor 4 expression." This patent provides antisense compounds, compositions, and methods for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions include antisense oligonucleotides targeted to nucleic acids encoding FGFR4. The methods outlined in this patent are aimed at treating diseases associated with the expression of FGFR4.
Another significant patent by Yu is related to the "Modulation of diacylglycerol acyltransferase 2 expression." This invention includes compounds, compositions, and methods for modulating the expression of diacylglycerol acyltransferase 2. The compositions consist of oligonucleotides targeted to the nucleic acid encoding this enzyme. The methods provided are intended for the diagnosis and treatment of diseases associated with the expression of diacylglycerol acyltransferase 2.
Career Highlights
Throughout his career, Xing-Xian Yu has worked with notable companies in the biotechnology sector, including Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. His work has significantly impacted the development of therapeutic strategies targeting gene expression.
Collaborations
Yu has collaborated with esteemed colleagues such as Sanjay Bhanot and Brett P Monia, contributing to the advancement of innovative solutions in biotechnology.
Conclusion
Xing-Xian Yu's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of therapies aimed at modulating gene expression, showcasing the importance of innovation in addressing complex medical challenges.